BD and the World Health Organization (WHO), together with Saving Lives at Birth: A Grand Challenge for Development partners, today announced a commitment to develop and launch the Odon Device, an obstetrical instrument for assisting the delivery of newborns during troublesome labor.
“Obstructed labor is a major killer of young women and adolescent girls,” said Dr. Margaret Chan, Director-General of the WHO. “The Odon Device offers a low-cost simplified way to deliver babies, and protect mothers, when labor is prolonged. It promises to transfer life-saving capacity to rural health posts, which almost never have the facilities and staff to perform a C-section.”
The Odon Device is designed to gently deliver newborns through the birth canal during complicated second-stage labor. BD will use its core competencies in medical device design, quality systems, process design and manufacturing to develop the Odon Device and establish high-scale, low-cost production. BD (Becton, Dickinson and Company) will offer affordable access pricing in developing countries. The device will initially be introduced in priority countries with a large burden of maternal mortality as determined by the WHO.
“When a mother or newborn dies during childbirth, it has a devastating impact on families and communities,” said Vincent Forlenza, Chairman, CEO and President, BD. “We are honored to work with the WHO and the Saving Lives at Birth partners to bring this truly innovative new device to scale and make it broadly accessible in the countries where it is most needed.”
Gary Cohen, Executive Vice President at BD, is Acting CEO of GBCHealth.